JSC "Farmak" (manufacturing of bulk products from manufacturers Bluepharma Industria Farmaceutica S.A., Portugal (manufacturing, primary and secondary packaging, batch control, batch release), AET Laboratories Private Limited, India (manufacturing, primary and secondary packaging, batch control, batch release))

Ukraine

All drugs from this manufacturer

  • AIGLIP

    The drug is intended for adults with type 2 diabetes mellitus as an adjunct to diet and physical exercise to improve glycemic control. It can be used either as monotherapy or in combination with other antidiabetic medications (e.g., insulin or metformin).

    Dosage form: tablets

    Active substance Dosage
    villogliptin 50 mg

    ATC: A10BH02